Skip to content
Clinical Trials – home
Verifiedinfo

DRK Kliniken Berlin

Germany Spandauer Damm 130, 14050 Berlin, Germany

  • 22 trials recruiting
  • Colitis ulcerative · Pulmonary arterial hypertension · Crohn's disease
  • Adults and children

About Specializations

DRK Kliniken Berlin in Berlin, Germany specialises in clinical trials of conditions such as Colitis ulcerative, Pulmonary arterial hypertension, Crohn's disease, Colorectal cancer metastatic, and other specialisations. This site conducts important research.

Main research areas of the site

Cardiovascular Diseases

At DRK Kliniken Berlin, clinical research in cardiovascular medicine focuses on reducing major heart and vascular events in people at elevated risk. The studies are designed to assess whether new treatments can better prevent serious outcomes such as heart attack, stroke, and other atherosclerotic cardiovascular disease complications.

  • Reducing the risk of major adverse cardiovascular events in high-risk patients
  • Evaluating new options for coronary heart disease prevention
  • Testing treatments aimed at improving long-term cardiovascular safety

These trials reflect a strong interest in finding more effective ways to prevent serious cardiovascular events and improve outcomes for people with obesity-related or heart-disease-related risk factors.

Neoplasms

The site also supports research in oncology, with a particular focus on breast cancer and metastatic colorectal cancer. The studies are exploring whether newer treatment approaches can improve cancer control and help prevent recurrence in patients with early-stage or advanced disease.

  • Studying treatment strategies for ER+/HER2- early breast cancer
  • Evaluating new approaches for metastatic colorectal cancer
  • Assessing whether emerging therapies can improve cancer recurrence prevention

This research highlights the role of Brustzentrum in advancing cancer care through trials that compare new therapies with established treatment standards.

Nutritional and Metabolic Diseases

Clinical trials in nutritional and metabolic diseases at this Berlin site are centered on obesity and related health risks. The research is examining whether new therapies can support better weight-related disease management while also lowering the chance of downstream cardiovascular complications.

  • Investigating treatments for obesity and related metabolic risk
  • Exploring links between weight management and cardiovascular health
  • Testing therapies intended to improve long-term disease prevention

These studies show a broad interest in conditions where metabolism, weight, and heart health overlap, with the goal of improving everyday care for patients at risk.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Spandauer Damm 13014050 BerlinGermany
Recruiting now
22 trials
Conditions studied
33
Partner status
Verified

More sites in BerlinGermany

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

45 clinical trials

Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Golimumab
  • Sponsor:Janssen - Cilag International
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:SPY002
  • Sponsor:Spyre Therapeutics Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:SPY002
  • Sponsor:Spyre Therapeutics Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:ZILEBESIRAN
  • Sponsor:Alnylam Pharmaceuticals Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Summit Therapeutics Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Sponsor:AstraZeneca AB

Crohn's disease

Recruiting
Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Morf-057
  • Sponsor:Morphic Therapeutic Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Elafibranor
  • Sponsor:Ipsen Bioscience Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Boehringer Ingelheim Espana S.A.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Pfizer Inc.

Crohn's disease

Recruiting
Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:ICOTROKINRA
  • Sponsor:Janssen - Cilag International
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Pertuzumab
  • Sponsor:Solti Group
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.